Lung Cancer Authority Joins OSUCCC – James

Internationally renowned lung cancer specialist David Carbone, MD, PhD, joined Ohio State’s faculty to develop and lead an OSUCCC – James Thoracic Oncology Center that will help physicians and scientists devise and optimize targeted approaches to treating this disease, the No. 1 cause of cancer death among both men and women in the United States. Carbone is an expert in the molecular biology of lung tumors, which includes understanding the genetic, proteomic and metabolic features of each patient’s cancer, and developing drugs that take advantage of this information to optimally target tumors. He came to Ohio State from Vanderbilt University, where he directed the Experimental Therapeutics Program and the Thoracic and Head and Neck Cancer programs at the Vanderbilt-Ingram Cancer Center. Carbone also led the Thoracic Oncology Center at Vanderbilt.

Renowned Oncologist Leads Breast Radiation Oncology

Julia White, MD, regarded as one of the world’s leading breast radiation experts, became the new director of breast radiation oncology at the OSUCCC – James and vice chair of Ohio State’s Department of Radiation Oncology. As a physician and radiation oncologist, her goal is to deliver radiation personalized to each patient’s cancer by using advanced technology to better treat breast tumors and improve survival. White chairs the national Radiation Therapy Oncology Group’s (RTOG) Breast Cancer Group and is on the National Cancer Institute Breast Cancer Steering Committee. She has served as principal investigator for a number of clinical studies that have helped establish standards of care for breast cancer.

Another Cancer Genetics Expert Comes Aboard

Paul Goodfellow, PhD, joined Ohio State’s faculty as a professor of Obstetrics and Gynecology and a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James. He was recruited from Siteman Cancer Center, Barnes Jewish Hospital, at the Washington University School of Medicine in St. Louis, Mo., where he was principal investigator for a Specialized Program of Research Excellence (SPORE) in Endometrial Cancer and co-directed the Hereditary Cancer Core. Goodfellow’s research focuses on identification and characterization of genetic events important in tumor initiation and progression, and on understanding molecular events that can be used to develop approaches to preventing and treating endometrial (uterine) and breast cancers.

Cancer Program Gains Specialist in Genomics and Tumor Sequencing

Sameek Roychowdhury, MD, PhD, a specialist in genomics and tumor sequencing whose research focuses on personalized approaches to patient treatment through genomics, was recruited to Ohio State as an assistant professor in the Department of Internal Medicine’s Division of Medical Oncology. He also is an assistant professor in the School of Biomedical Science’s Department of Pharmacology. Roychowdhury previously was at the University of Michigan, where between 2006 and 2012 he consecutively completed an internal medicine residency, a clinical fellowship in medical oncology and a postdoctoral fellowship. He had been a clinical lecturer in the Division of Hematology/Oncology at Michigan since 2011. Roychowdhury earned both his MD and his PhD in immunology at Ohio State, where he also received his undergraduate degree in molecular genetics.

Sign up to receive publications from the OSUCCC – James

Sign Up Now

Contact The James

General Inquiries




460 W. 10th Avenue
Columbus, OH 43210

Contact Us

Meet the Leaders

Leadership & Executive Cabinet at The James

Learn More